These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6602736)

  • 1. Natural history of M-MSV tumors in mice carrying endogenized Moloney leukemia virus.
    Chieco-Bianchi L; D'Andrea E; De Rossi A; Zanovello P; Ronchese F; Collavo D
    Haematol Blood Transfus; 1983; 28():275-9. PubMed ID: 6602736
    [No Abstract]   [Full Text] [Related]  

  • 2. A crucial role of the H-2 D locus in the regulation of both the D- and the K-associated cytotoxic T lymphocyte response against Moloney leukemia virus, demonstrated with two Db mutants.
    Stukart MJ; Vos A; Boes J; Melvold RW; Bailey DW; Melief CJ
    J Immunol; 1982 Mar; 128(3):1360-4. PubMed ID: 6799575
    [No Abstract]   [Full Text] [Related]  

  • 3. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
    [No Abstract]   [Full Text] [Related]  

  • 4. Natural suppressor cell inhibiting T killer responses against retroviruses: a model for self tolerance.
    Tilkin AF; Bègue B; Gomard E; Levy JP
    J Immunol; 1985 Apr; 134(4):2779-82. PubMed ID: 3156190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
    Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetic control of murine leukemias induced by Moloney virus].
    Debré P; Gisselbrecht S; Boyer B; Lévy JP
    Bull Cancer; 1982; 69(2):178-87. PubMed ID: 6812667
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunologic tolerance to antigens associated with murine leukemia viruses: T-cell unresponsiveness?
    Chieco-Bianchi L; Sendo F; Aoki T; Barrera OL
    J Natl Cancer Inst; 1974 Apr; 52(4):1345-50. PubMed ID: 4133203
    [No Abstract]   [Full Text] [Related]  

  • 8. Lack of T-cell mediated cytotoxicity in M-MSV system depending on H-2 haplotypes.
    Biasi G; Collavo D; Zanovello P; Colombatti A; Chieco-Bianchi L
    J Immunogenet; 1979 Oct; 6(5):341-51. PubMed ID: 315438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia.
    Nazarov V; Hilbert D; Wolff L
    Virology; 1994 Dec; 205(2):479-85. PubMed ID: 7975249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies to the envelope proteins of Moloney leukemia virus: characterization of recombinant viruses.
    Cicurel L; Lee JC; Enjuanes L; Ihle JN
    Transplant Proc; 1980 Sep; 12(3):394-7. PubMed ID: 7222218
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro cytotoxicity studies of murine sarcoma virus-induced immunity in mice.
    Lavrin DH; Herberman RB; Nunn M; Soares N
    J Natl Cancer Inst; 1973 Nov; 51(5):1497-508. PubMed ID: 4762933
    [No Abstract]   [Full Text] [Related]  

  • 12. Tolerance to viral antigens in Mov-13 mice carrying endogenized Moloney-murine leukemia virus.
    Ronchese F; D'Andrea E; Collavo D; De Rossi A; Zanovello P; Chieco-Bianchi L
    Cell Immunol; 1984 Feb; 83(2):379-88. PubMed ID: 6607132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic masking of nondefective recombinant murine leukemia virus in Moloney virus stocks.
    Fischinger PJ; Blevins CS; Dunlop NM
    Science; 1978 Aug; 201(4354):457-9. PubMed ID: 663667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic heterogeneity of Moloney leukemia virus-induced T cel lymphomas.
    Pepersack L; Lee JC; McEwan R; Ihle JN
    J Immunol; 1980 Jan; 124(1):279-85. PubMed ID: 6965293
    [No Abstract]   [Full Text] [Related]  

  • 15. Sister chromatid exchanges induced in vivo and in vitro by chemical carcinogens in mouse lymphocytes carrying endogenized Moloney leukemia virus.
    Majone F; Montaldi A; Ronchese F; De Rossi A; Chieco-Bianchi L; Levis AG
    Carcinogenesis; 1983; 4(1):33-7. PubMed ID: 6821887
    [No Abstract]   [Full Text] [Related]  

  • 16. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
    Flyer DC; Burakoff SJ; Faller DV
    J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement of histocompatible macrophages for the induction of a secondary cytotoxic response to syngeneic tumor cells in vitro.
    Taniyama T; Holden HT
    J Immunol; 1979 Jul; 123(1):43-9. PubMed ID: 312881
    [No Abstract]   [Full Text] [Related]  

  • 18. T cell-mediated immunity to oncornavirus-induced tumors. IV. Preliminary evidence for a specific suppression of anti-Moloney cell-mediated immune response by autoimmune T cells.
    Leclerc JC; Plater C; Connan F; Debré P
    Eur J Immunol; 1981 Jan; 11(1):45-7. PubMed ID: 6452279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immune response to primary Moloney sarcoma virus tumors in BALB-c mice: cellular and humoral activity of long-term regressors.
    Lamon EW; Anderson B; Wigzell H; Fenyö EM; Klein E
    Int J Cancer; 1974 Jan; 13(1):91-104. PubMed ID: 4594340
    [No Abstract]   [Full Text] [Related]  

  • 20. Moloney murine leukemia virus tolerance in anti-CD4 monoclonal antibody-treated adult mice.
    Biasi G; Facchinetti A; Panozzo M; Zanovello P; Chieco-Bianchi L; Collavo D
    J Immunol; 1991 Oct; 147(7):2284-9. PubMed ID: 1833453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.